UPC_CFI_165/2024

PROCESS FOR CONCENTRATION OF ANTIBODIES AND THERAPEUTIC PRODUCTS THEREOF

Einstweilige MaßnahmenEinstweilige MaßnahmenDusseldorf LDProvisional measuresCase Closed

Dieser Fall zitiert

In den Entscheidungen dieses Falls zitierte Quellen.

Quelle	Rechtsfrage	Bindungskraft	Auszug
Art. 25 UPCA	uniform substantive patent law; direct infringement	Bindend	Art. 25 UPCA constitutes uniform substantive law and Art. 62 (1) UPCA uniform procedural law, which takes precedence over national patent laws
Art. 62 UPCA	provisional measures; uniform procedural law	Bindend	Art. 25 UPCA constitutes uniform substantive law and Art. 62 (1) UPCA uniform procedural law, which takes precedence over national patent laws

Quelle	Rechtsfrage	Bindungskraft	Auszug
RoP_rule 295	stay of proceedings not applicable to provisional measures applications	Bindend	Rule R. 295 RoP (stay of proceedings) refers to actions and is therefore not applicable to applications for provisional measures.
RoP_rule 213	provisional measures; requirements for granting	Bindend	measures according to the clear wording of Rule 213.1 RoP.

Zitiert in

Spätere UPC-Entscheidungen, die diesen Fall zitieren.

Zitiert in	Datum	Rechtsfrage	Bindungskraft	Auszug
UPC_CFI_662/2025 Mannheim LD	3. Nov. 2025	commercial relationship for jurisdiction	Überzeugend	Lokalkammer Düsseldorf, Anordnung v. 06. September 2024, UPC CFI 165/2024, ACT_18492/2024 - Novartis/Celltrion